Altered intestinal microbial flora and impaired epithelial barrier structure and function in CKD: the nature, mechanisms, consequences and potential treatment.
about
New Pathogenic Concepts and Therapeutic Approaches to Oxidative Stress in Chronic Kidney DiseaseIatrogenic Iron Overload in Dialysis Patients at the Beginning of the 21st CenturyThe molecular mechanisms of hemodialysis vascular access failureResistant starch for modulation of gut microbiota: Promising adjuvant therapy for chronic kidney disease patients?Fecal Transplants: What Is Being Transferred?A reduction in the butyrate producing species Roseburia spp. and Faecalibacterium prausnitzii is associated with chronic kidney disease progression.Metabolic profiles of the Flos Abelmoschus manihot extract by intestinal bacteria from the normal and CKD model rats based on UPLC-Q-TOF/MS.Chronic Kidney Disease Induced Intestinal Mucosal Barrier Damage Associated with Intestinal Oxidative Stress Injury.Gene and protein expressions and metabolomics exhibit activated redox signaling and wnt/β-catenin pathway are associated with metabolite dysfunction in patients with chronic kidney disease.The nature, consequences, and management of neurological disorders in chronic kidney disease.Circulating trimethylamine N-oxide and the risk of cardiovascular diseases: a systematic review and meta-analysis of 11 prospective cohort studies.Oral iron supplementation: Potential implications for the gut microbiome and metabolome in patients with CKD.Intestinal Barrier Disturbances in Haemodialysis Patients: Mechanisms, Consequences, and Therapeutic Options.Intestinal Microbiota in Type 2 Diabetes and Chronic Kidney Disease.Gut microbiota in renal physiology: focus on short-chain fatty acids and their receptors.Kt/Vurea and Nonurea Small Solute Levels in the Hemodialysis Study.Mode of renal replacement therapy determines endotoxemia and neutrophil dysfunction in chronic kidney disease.Measurement of the intestinal permeability in chronic kidney disease.Effect of Synbiotic Therapy on Gut-Derived Uremic Toxins and the Intestinal Microbiome in Patients with CKD.Structural and functional differences in gut microbiome composition in patients undergoing haemodialysis or peritoneal dialysis.Effects of end-stage renal disease and dialysis modalities on blood ammonia level.Gut microbiota-derived short-chain fatty acids and kidney diseases.Dietary advanced glycation end products modify gut microbial composition and partially increase colon permeability in rats.Increased chronic kidney disease development and progression in diabetic patients after appendectomy: a population-based cohort study.Dietary Influence on Body Fluid Acid-Base and Volume Balance: The Deleterious "Norm" Furthers and Cloaks Subclinical Pathophysiology.Malnutrition in Chronic Kidney Disease.
P2860
Q26739475-CFD7C334-BFB0-4066-985B-191DF6C91738Q26752664-E0727D16-43FA-4799-922A-AC8B718CE580Q26775058-6B38521F-4CEA-46A8-A617-554B32285BD5Q35910146-2D805E08-9324-478E-97A2-DDAF0979B4F4Q36073899-08C57F56-189F-479C-991C-F74746890A67Q36081100-0618A07C-41C7-4223-98A8-A18D1366B051Q36083933-BDDAA7D2-7FE2-4600-8F7A-7617B4424D3DQ37132326-F249FAA3-AE58-465B-8BF1-0AB2554C35CAQ37724958-2A70B900-9915-4003-9B68-427C0089A567Q38629122-9B4C08B8-6222-482B-A708-34E242E73BCAQ38637363-C0970B41-AE12-4FE1-8EDF-323C77083E63Q38741680-650D02F2-1284-425F-8C7F-ECD8605D7572Q38757951-0B32E14B-D933-424B-B3EB-B8139197967FQ38921854-603DCE7A-16CB-4421-854A-2023608EC4D0Q38941009-2BB361A7-1D9D-458A-81B5-0D319D12E3EDQ40502560-FB4F60D7-B0D9-4A9F-9095-07EC88DBE490Q40518328-0B2B3F7A-2659-4986-B201-717716F50950Q40599724-71234277-83E4-446F-AF17-E5C0C4EEB55DQ42551130-FC27B99C-1C2D-4E62-AB46-070BABC9C960Q46260769-BA8E0D6B-DEE5-4CA5-B563-B5B6D0A8454BQ46632759-1FF4C450-4C76-496D-980C-E7A4171334D2Q47147649-3EB7BE93-81A7-49F5-8BE8-78FCD3FBD068Q48012355-8910AEB5-D26A-4381-BC06-44812B0AE693Q55411956-53E7DAE4-C6D2-4FF5-980C-808632E8E1CAQ55506559-3F7C099B-CFD0-494C-86C6-2AEAA016E006Q55512591-D394B72F-4E57-470E-A8CA-813BEC3E8787
P2860
Altered intestinal microbial flora and impaired epithelial barrier structure and function in CKD: the nature, mechanisms, consequences and potential treatment.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Altered intestinal microbial f ...... ences and potential treatment.
@en
type
label
Altered intestinal microbial f ...... ences and potential treatment.
@en
prefLabel
Altered intestinal microbial f ...... ences and potential treatment.
@en
P2860
P356
P1476
Altered intestinal microbial f ...... uences and potential treatment
@en
P2093
Madeleine V Pahl
Nosratola D Vaziri
P2860
P304
P356
10.1093/NDT/GFV095
P407
P577
2015-04-16T00:00:00Z